Fusion Antibodies Plc (FAB:LSE) Investor Relations Material

Overview

Fusion Antibodies Plc is a company focused on discovering antibodies that can help revolutionize the healthcare industry. The company provides a comprehensive range of services related to antibodies, including discovery, engineering, and supply. They have successfully guided many projects through vital preclinical stages. The company's mission is to bring about a positive change in the healthcare industry by developing and discovering antibodies that can help treat various diseases.

Frequently Asked Questions

What is Fusion Antibodies Plc's ticker?

Fusion Antibodies Plc's ticker is FAB

What exchange is Fusion Antibodies Plc traded on?

The company's shares trade on the LSE stock exchange

Where are Fusion Antibodies Plc's headquarters?

They are based in Belfast, Northern Ireland

How many employees does Fusion Antibodies Plc have?

There are 11-50 employees working at Fusion Antibodies Plc

What is Fusion Antibodies Plc's website?

It is https://www.fusionantibodies.com/

What type of sector is Fusion Antibodies Plc?

Fusion Antibodies Plc is in the Healthcare sector

What type of industry is Fusion Antibodies Plc?

Fusion Antibodies Plc is in the Biotechnology industry

Who are Fusion Antibodies Plc's peers and competitors?

The following five companies are Fusion Antibodies Plc's industry peers:

- G1 Therapeutics

- Zynerba Pharmaceuticals, Inc.

- Outlook Therapeutics

- Cidara Therapeutics Inc

- Inovio Pharmaceuticals